3β-HSD III

3β-Hydroxysteroid dehydrogenase (3β-HSD) catalyzes the oxidative conversion of Δ5-3β-hydroxysteroids into Δ4-3-ketosteroids and is therefore required for the biosynthesis of progesterone, glucocorticoids, mineralocorticoids, androgens, and estrogens^[1][2]. The 3β-HSD enzymatic system functions at a central step in steroid hormone metabolism by converting pregnenolone to progesterone and dehydroepiandrosterone to androstenedione, thereby linking precursor steroid production with downstream endocrine signaling pathways^[1][2]. In disease settings, defects in HSD3B2 impair the synthesis of multiple steroid classes and cause 3β-HSD deficiency, a rare form of congenital adrenal hyperplasia characterized by adrenal insufficiency, disordered sex hormone synthesis, and abnormal sexual development^[3][4]. Mechanistically, the severity of clinical phenotypes correlates with the underlying HSD3B2 mutations and residual enzyme activity, making this pathway a valuable experimental model for investigating steroidogenic dysfunction^[3]. Compared with the well-characterized HSD3B1 and HSD3B2 isoforms, which display distinct tissue expression patterns in peripheral tissues, placenta, adrenal gland, ovary, and testis, the designation 3β-HSD III (HSD3B3) remains considerably less defined in the current literature and lacks the extensive functional characterization available for the major human isoenzymes^[2][1]. Therefore, current research applications primarily rely on established HSD3B1/HSD3B2 steroidogenic models to investigate enzyme function, disease mechanisms, and steroid biosynthesis regulation^[2][3].